Epigen Biosciences INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Diego, CA
SAM.gov UEIL1EDVCGK2327
Epigen Biosciences develops novel therapeutic compounds, specifically an LPA1R antagonist, for treatment of diabetic kidney disease, non-alcoholic steatohepatitis, and idiopathic pulmonary fibrosis. The company focuses on addressing areas of high unmet medical needs through proprietary compound development across multiple therapeutic areas.
Summarized from the company’s own website
Their plants
2 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Epigen Biosciences INC | San Diego | CA | — | UNVERIFIED |
| Epigen Biosciences INC | San Diego | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.